Evidence map›Paper›PMID 33836079›Full record

ArticleNucleic acids research2021

Myod1 and GR coordinate myofiber-specific transcriptional enhancers.

Daniela Rovito, Anna-Isavella Rerra, Vanessa Ueberschlag-Pitiot, Shilpy Joshi, Nezih Karasu, Vanessa Dacleu-Siewe, Khalil Ben Rayana, Kamar Ghaibour, Maxime Parisotto, Arnaud Ferry and 7 more

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cloning and Transcriptional Activity Analysis of the BovineAnimals : an open access journal from MDPI · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 2 countries.

Daniela RovitoUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Anna-Isavella RerraUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Vanessa Ueberschlag-PitiotUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Shilpy JoshiUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Nezih KarasuUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Vanessa Dacleu-SieweUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Khalil Ben RayanaUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Kamar GhaibourUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Maxime ParisottoUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Arnaud FerryCentre de Recherche en Myologie, UMRS974-Sorbonne Université-INSERM U974-Association Institut de Myologie, France.
Scott A JelinskyDepartment of Inflammation and Immunology, Pfizer Research, Cambridge, MA, USA.ORCID 0000-0002-5114-0236
Gilles LavernyUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Bruno P KlaholzUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.ORCID 0000-0001-8674-8674
Tom SextonUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Isabelle M L BillasUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.
Delphine DuteilUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.ORCID 0000-0001-5826-0153
Daniel MetzgerUniversité de Strasbourg, CNRS UMR7104, INSERM U1258, IGBMC, F-67400 Illkirch, France.ORCID 0000-0002-5555-046X
Centre National de la Recherche Scientifique · FRInserm · FRPfizer (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeletal muscle is a dynamic tissue the size of which can be remodeled through the concerted actions of various cues. Here, we investigated the skeletal muscle transcriptional program and identified key tissue-specific regulatory genetic elements. Our results show that Myod1 is bound to numerous skeletal muscle enhancers in collaboration with the glucocorticoid receptor (GR) to control gene expression. Remarkably, transcriptional activation controlled by these factors occurs through direct contacts with the promoter region of target genes, via the CpG-bound transcription factor Nrf1, and the formation of Ctcf-anchored chromatin loops, in a myofiber-specific manner. Moreover, we demonstrate that GR negatively controls muscle mass and strength in mice by down-regulating anabolic pathways. Taken together, our data establish Myod1, GR and Nrf1 as key players of muscle-specific enhancer-promoter communication that orchestrate myofiber size regulation.

Indexed as

Enhancer Elements, GeneticAnimalsCell LineChromatinChromatin Immunoprecipitation SequencingGene Expression RegulationHistonesMaleMetabolic Networks and PathwaysMiceMice, Inbred C57BLMice, KnockoutMuscle, SkeletalMuscle StrengthMyoblastsMyoD ProteinChromatinhistone H3 trimethyl Lys4HistonesMyoD1 myogenic differentiation proteinMyoD ProteinNrf1 protein, mouseNuclear Respiratory Factor 1Receptors, GlucocorticoidRecombinant Proteins

Identifiers

PMID33836079
PMCPMC8096230
OpenAlexW3143079176

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.